Analysis of the Costs Associated with the Management of Adverse Events Compared Through Tkis in the Treatment of Patients with Non-Small Cells Lung Cancer EGFR Mutated
Abstract
Authors
S Villa E Brioschi R Ravasio
S Villa E Brioschi R Ravasio
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now